SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

NONJA CRYPTO is experiencing heightened interest as its passionate community rallies around the Injective ($INJ) ecosystem's growth, driven by recent network developments like the EVM mainnet launch and anticipated INJ ETFs. Many perceive $NONJA as a high-leverage opportunity on Injective's trajectory, emphasizing its strong community and robust liquidity as key factors for significant future gains.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash (ZEC) is experiencing a surge of community interest driven by its robust privacy features and recent institutional endorsements. Developments like increasing shielded transaction usage, a major network upgrade, and Grayscale's push for an ETF are fueling widespread speculation about its potential as the 'better Bitcoin'.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending following its acquisition of Melt Pharmaceuticals and ahead of its Investor Day, where the company is expected to detail a path to significant revenue growth. Community sentiment is highly bullish, driven by anticipated Vevye market share expansion through major insurance formulary wins and speculation about short covering fueling further price momentum. Many investors believe the stock is currently undervalued, positioning it for substantial long-term gains within the ophthalmic sector.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is gaining significant attention, propelled by its AI-powered Athena platform and recent Marigold acquisition. The community is highly optimistic, discussing its perceived undervaluation and anticipating a substantial rerating as GAAP profitability nears and its leadership in AI-driven MarTech with first-party data is increasingly recognized. This positions Zeta as a key player in the evolving digital advertising landscape.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is experiencing intense debate amidst mixed signals, as news of SWIFT choosing an Ethereum L2 solution for cross-border payments conflicts with reports of continuous XRP ETF inflows and new merchant adoptions like SPAR. The community remains sharply divided, with bulls highlighting long-term utility and anticipated regulatory clarity from the 'Clarity Act' for a future price surge, while skeptics point to ongoing escrow dumps and perceived manipulation contributing to its current stagnation.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is surging, fueled by impending export restrictions from China taking effect at the New Year, which is amplifying scarcity concerns amid rising industrial demand for critical technologies like EVs and AI data centers. This has ignited a fierce debate, with many predicting a historic short squeeze and significant further upside due to years of suppression and dollar debasement, while others caution about a parabolic blow-off top after an aggressive rally.

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Sutro Biopharma Inc

Sutro Biopharma is trending due to its recent reverse stock split, which helped it regain Nasdaq listing compliance, alongside a major corporate restructuring and workforce reduction. The community is actively debating the deprioritization of its lead asset, Luvelta, and the company's strategic pivot towards its next-generation ADC programs. Many investors are keenly focused on the potential for new partnerships for Luvelta and upcoming pipeline milestones, given the company's substantial cash reserves within the competitive biotech sector.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending with significant community buzz, largely fueled by its integration-ready post-quantum vault development, which positions it as a technically advanced peer-to-peer electronic cash. Amidst broader market volatility, many investors are observing BCH's remarkable resilience and discussing its potential for a major breakout, with sentiments indicating it is "extremely undervalued" and poised for substantial upside. This has fostered a strong "Hodl gang" conviction, as participants anticipate BCH's performance in a potential altcoin season.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is drawing attention amidst strong community discussion around its leading meme coin, $NONJA, frequently highlighted as a high-leverage play on the INJ ecosystem due to its active community and burned liquidity. This interest is amplified by news of Pineapple Financial's $100 million fundraise to acquire and stake INJ, signaling growing institutional confidence in Injective's robust financial infrastructure and deflationary tokenomics.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending amidst escalating investor frustration over management's prolonged silence and the looming proxy fight initiated by activist investor Shah Capital demanding leadership change. The community is intensely speculating on a potential buyout or significant partnership deal for its non-mRNA vaccine technology and Matrix-M adjuvant, with some linking this urgency to Sanofi's recent acquisition of Dynavax and increasing discussions around black box warnings for mRNA vaccines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


CEPH
Cephalon Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest CEPH News

CEPHCephalon Inc.